VENTURE CAPITAL POST

Several major drug companies, including Pfizer, Sanofi, and Takeda Pharmaceutical, are gearing up to implement price hikes on over 500 drugs in the United States in early January.

GlaxoSmithKline pledged not to file patents to make drugs more affordable to poor countries. Any GSK drugs that are included in the list of the World Health Organization's important medicines will be included automatically.

Last July, when Federal Reserve Chair Janet Yellen spurred a sell-off in healthcare stocks by saying that valuations in shares of biotech companies looked "stretched," portfolio manager Graham Tanaka saw an opportunity.

Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc for $8.3 billion in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector.

The approval for a bridge loan was given to McKesson to facilitate its acquisition of Celesio AG.

Pharmaceutical giants Pfizer, AstraZeneca and Novartis are among those to propose bids for Onyx Pharmaceuticals.

Ipsen announced the acquisition of UK-based private life sciences company, Syntaxin.

Pfizer invests in two plants in Ireland.

CFR Pharmaceuticals has embarked on a South African road show starting June 08.

Cipla Ltd offers to take over Cipla Medpro South Africa.

Royalty Pharma has been making big approaches to acquire the royalty rights for Tysabri from the Irish drug maker.

Progenics Pharmaceuticals today announced that it has acquired Molecular Insight Pharmaceuticals